Long-Term Organ Preservation in Rectal Cancer Is Possible
Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/998830?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/998830?src=rss
Comments
Post a Comment